Director, Respiratory Biologics – Global Real-World Evidence & Health Outcomes Research

GSK

Director for Respiratory Biologics at GSK, overseeing real-world evidence for product lifecycle management. Engaging with global partners to support product positioning and market entry strategies.

Posted 7/13/2026full-timeUpper Providence • Pennsylvania • 🇺🇸 United StatesLead💰 $185,250 - $308,750 per yearWebsite

Core Competencies

Role fit

Core Competencies

Use this summary to align your resume positioning with the role.

Demonstrates expertise in health outcomes data generation, evidence-based product positioning, and strategic collaboration across cross-functional teams. Proficient in developing and executing study designs and project plans to support market access and reimbursement strategies.

Highest-signal resume keywords

Health Outcomes Data GenerationEvidence Generation PlanningPatient Reported Outcomes ResearchHealth Technology Assessment SubmissionsCross-Functional Collaboration

ATS Keywords

Tailor your resume

Applicant Tracking System Keywords

Tip: use these terms in your resume and cover letter to boost ATS matches.

Hard Skills

Evidence Generation PlanningStudy DesignProject ManagementReal-World Evidence StudiesPatient Reported OutcomesHealth EconomicsEpidemiologyPharmacyData DisseminationCommunications

Soft Skills

Stakeholder EngagementStrategic AlignmentEffective CommunicationRelationship BuildingCollaboration

Certifications & Qualifications

Masters in Health OutcomesMasters in Health EconomicsMasters in EpidemiologyMasters in PharmacyMasters in Life Sciences

Industry Keywords

Pharmaceutical IndustryMarket AccessReimbursement Decision MakingHealthcare MarketsHealth Technology Assessment

About the role

Key responsibilities & impact

For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position
Evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors
Support asset teams to ensure that each medicine GSK brings to market is supported by scientifically credible, high quality, evidence that drives competitiveness and strong evidence-based product positioning, value propositions and value-based pricing
Engage closely with global and country level data generation partners
Actively support data generation planning, study design, execution, translation and dissemination across indications for the asset
Build strong working relationships with stakeholder groups across countries, medical, market access, R&D and commercial to ensure strategic alignment and optimal cross-functional collaboration and communication

Requirements

What you’ll need

Masters in health outcomes, patient reported outcomes, health economics, epidemiology, pharmacy, health or life sciences
10 + years’ experience working in pharmaceutical industry, preferably in a multi-national company
Experience with evidence generation planning and workshop development
Experience developing detailed project and program plans
Experience delivering studies and related communications to the matrix in a fast-paced environment
Experience with a variety of study designs, i.e., RWE studies including prospective, cross-sectional and retrospective cohort studies
Must have experience with patient reported outcomes research
Knowledge of the diversity and complexity of healthcare markets, health technology assessment agencies, and reimbursement decision making globally, in region and in local markets
Applied experience in utilizing evidence for the development of HTA submissions, reimbursement and/or medical engagement
Experience communicating technical and complex concepts and results effectively to various audiences to impact decision-making, including impactful slide presentations to senior leaders.

Benefits

Comp & perks

health care and other insurance benefits (for employee and family)
retirement benefits
paid holidays
vacation
paid caregiver/parental and medical leave
annual bonus
eligibility to participate in our share based long term incentive program